Merck & Co (MRK)
$77.18 0.45 (0.59%)
7:37 EDT MRK Stock Quote Delayed 30 Minutes
Previous Close $76.73
Market Cap 207.64B
PE Ratio 133.07
Volume (Avg. Vol.) 1,006
Day's Range 76.73 - 76.73
52-Week Range 65.25 - 92.64
Dividend & Yield 1.92 (2.49%)
MRK Stock Predictions, Articles, and Merck & Co News
- From InvestorPlace
- From the Web
Merck is a great company with a leading coronavirus vaccine candidate. Despite all that, upside is limited for MRK stock. Stay away.
Much of the conversation about pharmaceutical stocks rests on the coronavirus, but these high-growth names have potential beyond the pandemic.
Merck stock has outperformed large-cap pharma stocks. But that's a low bar to clear, leaving investors with more attractive options elsewhere.
Moderna, a stock that doesn't reside in the Dow Jones Industrial Average, sent the blue chip index soaring to start the week.
In another instance of the market fighting off weak economic data, stocks rallied Thursday despite another spike in weekly jobless numbers.
Stocks swooned Wednesday after Federal Reserve Chairman Jerome Powell said the novel coronavirus is creating lingering uncertainty for the U.S. economy while scoffing at the notion that negative interest rates could help the world's largest economy regain its footing.
The major equity averages didn't do much of anything Tuesday even as several big names reported earnings before the opening bell. Fortunately, there was some decent commentary from those companies, albeit cautious, indicating that the U.S. economy could start rebounding in the second half of the year.
Merck (MRK) earnings for the pharmaceutical company's first quarter of 2020 have MRK stock falling Tuesday despite beating estimates.
Tuesday's big stock charts feature health-care-sector names that may offer value and leadership.
There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.
Wednesday's big stock charts feature names that are preparing to meet with their significant support lines.
Stocks stumbled again Tuesday as the ongoing decline in the oil pitch, coupled with fears a new coronavirus stimulus package will prove inadequate in bolstering the economy, served confirmation that a recession is setting in.
Friday was a down day, but four of the past five have been up days for the Dow and it's worth pointing out that after one of the most rapid corrections/bear markets on record, plenty of bad news is already being consumed, but plenty of uncertainty lingers, too.
Stocks popped Friday as investors sought coronavirus clarity from the White House and speculated the Fed could cut rates to zero.
Tuesday's 3 big stock charts feature suddenly unloved names that have traded back to past lows — and thus need support to hold.
Merck's proposed spinoff of women's health and other prescription drug businesses looks to boost growth and upside for MRK stock.
Merck stock fell on news it will spin off slow-growth areas to focus on Keytruda, its anti-cancer immunotherapy blockbuster.
Merck (MRK) earnings for the healthcare company's fourth quarter of 2019 have MRK stock down Wednesday on major spin-off news.
From Market News Video
Investors in Hershey Company (HSY) saw new options become available today, for the August 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the HSY options chain for the new August 14th contracts and identified one put and one call contract of particular interest.
From Seeking Alpha
From Talk Markets
Navellier RatingsPowered by Portfolio Grader